Michael Bonner - 17 Mar 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chief Financial Officer
Signature
Michael Bonner
Issuer symbol
CPIX
Transactions as of
17 Mar 2021
Net transactions value
-$24,661
Form type
4
Filing time
11 Jun 2021, 17:07:58 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Tax liability $3,436 -1,067 -5.3% $3.22 19,220 17 Mar 2021 Direct F1
transaction CPIX Common Stock Other $21,225 -7,500 -39% $2.83 11,720 17 May 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Award $0 +5,000 $0.000000 5,000 17 Mar 2021 Common Stock 5,000 $3.22 Direct F3
transaction CPIX Options (right to buy) Disposed to Issuer $0 -5,000 -100% $0.000000* 0 17 May 2021 Common Stock 5,000 $3.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Michael Bonner is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This transaction represents shares purchased by the Company to cover the tax withholding obligations for the vesting of shares.
F2 Resigned position as Chief Financial Officer effective May 17, 2021. All unvested equity awards forfeited upon resignation.
F3 100% vesting on March 17, 2025.